BREAKING NEWS
Covid-19 Drugs
Covid-19 Drugs
Source: COVID-19 Drugs  Oct 15, 2021  2 days ago
COVID-19 Drugs: A new study that analyzes real-world data utilizing artificial intelligence by researchers from AdventHealth Research Institute-Orlando, Oak Ridge National Laboratory-Tennessee and the University of Tennessee has found that the antiemetic drug Zofran (Ondansetron) lowers risk of mortality of severe COVID-19 patients on ventilators and is associated with increased survival of these ...
Source: Monoclonal Antibodies-SARS-CoV-2 Variants  Oct 07, 2021  10 days ago
Monoclonal Antibodies-SARS-CoV-2 Variants: If anything, the COVID-19 pandemic has revealed to those intelligent enough to understand anything that the elites in the United States are nothing more than the most filthy, unethical and greedy and corrupted live forms ever to emerge this earth.   From day one of the pandemic, certain American elites have been controlling the narratives of the COV...
Source: COVID-19 Exposé   Sep 24, 2021  23 days ago
COVID-19 Exposé : First it was the Trump Administration along with the U.S.NIH or to be specific the NIAID headed by Anthony Fauci that poured millions of dollars in to the development and research of the overpriced drug remdesivir that is not only hepatoxic but also nephrotoxic to treat COVID-19. There are tons of studies that confirm its toxicity issues, these are just a few.   http...
Source: COVID-19-Drugs  Sep 22, 2021  25 days ago
COVID-19 Drugs: A researcher from the University of Lahore Pakistan has proposed that the drug aprepitant could be used to target the neurokinin-1 receptors to prevent COVID-19 cytokine storms.   Aprepitant is a medication used in the management and treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It is in the neurokinin-1 a...
Source: COVID-19 Drugs  Sep 16, 2021  1 month ago
COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...
Source: COVID-19 Drugs-Fluvoxamine  Sep 06, 2021  1 month ago
COVID-19 Drugs: Results from the TOGETHER multi-institutional, multi-country randomized platform clinical trials of various repurposed drugs to treat COVID-19 has shown that  treatment with fluvoxamine (100mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization.   The institutions ...
Source: COVID-19 Drugs  Sep 04, 2021  1 month ago
COVID-19 Drugs: Researchers from the University of California-San Francisco along with support from Stanford University are exploring the use of the abortion drug Ethacridine to inhibit SARS-CoV-2 by inactivating viral particles and to assess its potential as a prophylaxis and also therapeutic agent to treat COVId-19. Their study findings were published in the peer reviewed journal: PLOS Pathogen...
Source: Pulmonary Fibrosis  Sep 01, 2021  2 months ago
A new breakthrough study by researchers from University of Alabama at Birmingham-USA has found that the drug Venetoclax used to treat adult patients with Chronic Lymphocytic Leukemia (CLL) could be repurposed to reverse lung fibrosis after successful mouse model drug trials. Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymp...
Source: COVID-19 Drugs  Sep 01, 2021  2 months ago
Researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Spain and the IIS-Fundación Jiménez Díaz University Hospital-Spain have in a new clinical study discovered that metprolol- a cheap drug widely used to treat cardiovascular disease, is beneficial in treating severely ill COVID-19 patients.   Metoprolol, sold under the brand name Lopressor, amo...
Source: COVID-19 Drugs  Aug 21, 2021  2 months ago
COVID-19 Drugs: A detailed meta-analytical study by researchers from the University of Virginia-USA, Humboldt-Universität zu Berlin-Germany,  Freie Universität-Germany and  Berlin Institute of Health, of previous research findings including clinical trials has revealed that the heartburn drug famotidine used alongside Aspirin has the potential to prevent disease severity a...
Source: COVID-19 Drugs-Fluvoxamine  Aug 14, 2021  2 months ago
COVID-19 Drugs: Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19. Speculations are adrift that Canada might be the first country to approve its usage to treat COVID-19 followed by the United States, India, Brazil and South Africa.   Fluvoxamine, sold under the brand name Luvox among others, is an antid...
Source: COVID-19 Drugs  Aug 13, 2021  2 months ago
Despite so many small randomized clinical trials and observational studies that showed Ivermectin could be used to treat COVID-19 during the early stages of the COVID-19 pandemic, physicians, researchers and individuals should stop attempting to treat COVID-19 with Ivermectin as the drug as no efficacy against most of the new variants that are currently dominating various countries. Thailand Medi...
Source: COVID-19 Therapeutics  Aug 09, 2021  2 months ago
COVID-19 Therapeutics: A new research led by scientists from Yale University along with other experts from University of Minnesota and Iowa State University has found that a crucial enzyme known as the Coronavirus 3′–5′ exoribonuclease (ExoN) promotes antiviral resistance hence making many identified drugs such as remdesivir, ivermectin and even identified antiviral phytochemical...
Source: COVID-19 Drugs  Aug 07, 2021  2 months ago
COVID-19 Drugs: A new mouse based vivo study by researchers from the Scripps Research Institute-California along with scientist from the University of Texas and Sorrento Therapeutics Inc.-California have found that salicylanilides which are active pharmaceutical ingredients (APIs) found in drugs used to treat tapeworm infestations demonstrated efficacy in terms of inhibiting the SARS-CoV-2 coronav...
Source: COVID-19 Drugs  Aug 07, 2021  2 months ago
COVID-19 Drugs: Scientists from the University of Birmingham and Keele University in the UK and the San Raffaele Scientific Institute in Italy have demonstrated that the licensed cholesterol lowering drug fenofibrate and its active form (fenofibric acid) can significantly reduce SARS-COV-2 infection in human cells in the laboratory. Importantly, reduction of infection was obtained using conce...
Source: COVID-19 Drugs  Aug 04, 2021  2 months ago
COVID-19 Drugs: A new in vitro study conducted by researchers from University of Georgia-US and Shahid Beheshti University-Iran has found that the common high pressure drug called Losartan is able to inhibit SARS-CoV-2 coronavirus replication.   Losartan, sold under the trade name Cozaar among others, is a medication mainly used to treat high blood pressure. Losartan belongs to a gr...
Source: miRNAs and SARS-CoV-2  Aug 02, 2021  3 months ago
COVID-19 Therapeutics: Researchers from Gujarat University inspired by Thailand Medical News call to focus on Phytochemicals and microRNAs as solutions to containing the SARS-CoV-2 pandemic have in a new study utilizing computational workflow, identified potential cellular miRNA candidates that are potent in providing antiviral defense against SARS-CoV-2 infection. The study team designed a syste...
Source: COVID-19 Drugs-Budesonide  Jul 29, 2021  3 months ago
Another study finding has emerged proving the antiviral effects of Budesonide when used either as an inhaler or as a nasal spray.   German researchers from the Ruhr-University Bochum and also from the European Virus Bioinformatics Center (EVBC) based in Jena-Germany have in a new study confirmed the viral effects of Budesonide against the wildtype SARS-CoV-2 coronavirus and even against the ...
Source: COVID-19 Antivirals  Jul 29, 2021  3 months ago
A new study by scientists from the National Institutes for Food and Drug Control (NIFDC)-China has found that lectins derived from lentils (Lens culinaris)- a staple in Indian cuisine often known as dhal, exhibits antiviral properties against the SARS-CoV-2 coronavirus. The study findings were published in the peer reviewed journal: Emerging Microbes and Infection. https://www.tandfonline.com/doi...
Source: Breaking COVID-19 News  Jul 28, 2021  3 months ago
A new study by researchers from the University of Reading, Reading, United Kingdom has found that inflammation and blood clotting seen in very severe cases of COVID-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs. According to the study team a subset of patients with COVID-19 typically become critically ill, suffering from severe ...
Source: Herbs and Phytochemicals for COVID-19.  Jul 24, 2021  3 months ago
As the COVID-19 pandemic fast accelerates into a more catastrophic mode and there are still no effective antivirals to date plus antibody therapies as well as vaccines are beginning to show signs of being defeated by the new emerging variants, there is a dire need for effective therapeutics against the SARS-CoV-2 coronavirus and various study teams around the world are frantically searching for pr...
Source: Epstein-Barr virus and COVID-19  Jul 22, 2021  3 months ago
A number of studies are emerging that indicate Epstein-Barr virus (EBV) reactivation may play a role both in the development of long COVID symptoms, as well as severe COVID-19 cases. It has been found that Coronavirus disease 2019 (COVID-19) patients sometimes experience long-term symptoms following resolution of acute disease, including fatigue, brain fog, and rashes.   One study published ...
Source: COVID-19 Drugs  Jul 19, 2021  3 months ago
A new study by biotech researchers from Hangzhou-China involved in a development of new drug formulation has found that N-Acetylneuraminic Acid (NANA)  and its analogs such as acetylneuraminic acid methyl ester (NANA-Me) are able prevent and also treat adverse reactions caused by COVID-19 infections and also by COVID-19 vaccines. Edible Bird's Nest- A Good Source Of N-Acetylneuramin...
Source: COVID-19 Drugs-Statins  Jul 16, 2021  3 months ago
COVID-19 Drugs: A new study by researchers from the University of California-San Diego School Of medicine-USA has confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19. According to the study team, statins have anti-inflammatory and immunomodulatory effects that may reduce the severity of the COVID-19 disease, in which organ dysfunction i...
Source: COVID-19 Therapeutics  Jul 15, 2021  3 months ago
COVID-19 Therapeutics: A new study by researchers from University of Fukui-Japan shows that Short Chain Fatty Acids (SCFAs) could be used as potential therapeutics to treat COVID-19 and also to act as a prophylaxis. The researchers showed that SCFAs could downregulate ACE2 in epithelial cells. According to the study team inflammatory endotype affects ACE2 expression in the nasal mucosa and influe...
Source: COVID-19 Clinical Care-Heparin  Jul 14, 2021  3 months ago
COVID-19 Clinical Care: A new study undertaken by medical researchers from the St. Michael's Hospital, a treatment site of Unity Health Toronto and the University of Vermont Larner College of Medicine indicates that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could halt the thrombo-inflammation process and reduce the risk of...
Source: COVID-19 Drugs-Aspirin  Jul 14, 2021  3 months ago
Aspirin-COVID-19: A detailed systematic review and meta-analysis study by researchers from the Michigan State University, USA has found that aspirin usage is associated with a significant reduction in overall and in-hospital mortality rates. The current COVID-19 pandemic has so far caused more than 4.05 million deaths and far more are expected to die in coming surges.   The benefits of aspir...
Source: Coronavirus News  Jul 03, 2021  4 months ago
Coronavirus News: A new study by researcher from Université Paul Sabatier-France, Ecole Nationale Vétérinaire d’Alfort-France,  Université Grenoble Alpes-France and also involving scientist from Ghent University-Belgium has shown that mannose-specific lectins derived from plants, algae, fungi, and bacteria selectively bind N-glycans present on the surface of ...
Source: COVID-19 Drugs  Jul 03, 2021  4 months ago
COVID-19 Drugs: A new study by American and Swiss researchers from University of Pennsylvania , University of Maryland, National Institutes of Health-USA and Epithelix-Switzerland demonstrates that usage of pyrimidine biosynthesis inhibitors such as Mycophenolate, Azathioprine And Leflunomide in conjunction with nucleoside analogs (Examples of such nucleoside analogs  include Remdesivir and M...
Source: COVID-19 Drugs And Supplements  Jul 01, 2021  4 months ago
COVID-19 Treatments: A new study by researchers from the Royal Institute of Technology-Sweden, University of Health Sciences-Turkey, Istanbul Technical University-Turkey, Atatürk University-Turkey, Chalmers University of Technology-Sweden, University of Gothenburg and Sahlgrenska University Hospital-Sweden and Istanbul Medipol University-Turkey has found that metabolic activators such as nico...
Source: COVID-19 Drugs  Jun 30, 2021  4 months ago
Remdesivir the controversial drug that was deemed to be ineffective in WHO’S SolidarityTrial (https://www.thailandmedical.news/news/latest-who-s-solidarity-drug-trial-shows-that-remdesivir-is-not-the-least-effective-in-treating-covid-19) but is still being approved as a drug to treat COVID-19 under EUA status in the United States by the no longer credible US FDA is now facing more backlash a...
Source: COVID-19 Drugs  Jun 29, 2021  4 months ago
The pharma and research industry has been abuzz the last few days after the preliminary release of a WHO registered randomized clinical trial results involving the usage of an Indian approved nutraceutical compound called Vedicinals-9 as an adjuvant to treat COVID-19. Not only were the results found to be extremely encouraging in terms of a therapeutic agent to treat COVID-19 but the product was a...
Source: COVID-19 Drugs  May 31, 2021  5 months ago
COVID-19 Drugs: Canadian researchers from the Montreal Heart Institute (MHI) and the Université de Montréal announced the clinical trial findings of the COLCORONA study (NCT04322682), which was  a phase 3, randomized, double-blind, adaptive, placebo-controlled, multicentre trial of the oral anti-inflammatory medication called Colchicine on hospitalized COVID-19 patients. The stu...
Source: COVID-19 Drugs  May 08, 2021  5 months ago
COVID-19 Drugs: About 3 hours ago, the Indian drug regulatory body, DCGI has granted emergency approval for the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad, as an adjuvant drug to treat hospitalized COVID-19 patients and also to reduce supplemental oxygen dependence. &n...
Source: COVID-19 Drugs  May 06, 2021  5 months ago
COVID-19 Drugs:  A new research by researchers from Japan shows that the teratogenic drug: Favipiravir that certain ignorant countries are using to treat COVID-19 can also induced liver injury if the serum concentration of the drug exceeds a certain threshold!   The study findings were published on a preprint server and are currently being peer reviewed by teams from the United States ...
Source: Aspirin-COVID-19  Mar 21, 2021  7 months ago
A new study led by researchers from George Washington University and also included scientists from the University of Maryland, Wake Forest School of Medicine, Northeast Georgia Health System, Walter Reed National Military Medical Center, University of California-San Francisco and the University of Oklahoma School of Medicine have found that low dose aspirin may reduce the need for mechanical venti...
Source: COVID-19 Antivirals  Feb 04, 2021  9 months ago
COVID-19 Antivirals: Japanese researchers from National Institute of Infectious Diseases, Tokyo and the Tokyo University of Science have in a new study found that oxidized cholesterol derivatives or oxysterol exhibits potent antiviral activity against the SARS-Cov-2 coronavirus.   Developments of effective antiviral drugs targeting SARS-CoV-2 are urgently needed to combat the COVID-19 disea...
Source: COVID-19 Treatments  Feb 03, 2021  9 months ago
COVID-19 Treatments: A new study by researchers from National Taiwan University Hospital and National Taiwan University College of Medicine has found that zinc supplementation enhances the efficacy of certain repurposed drugs such as triclabendazole and emetine. The SARS-CoV-2 has caused vast number of infections and fatalities worldwide with almost 104 million infections and more than 2.25 milli...
Source: COVID-19 Drugs  Feb 01, 2021  9 months ago
COVID-19 Drugs: A new study by researchers from University of Montreal-Canada,New York University-USA, Universidad Autónoma de Madrid-Spain, Universidade de São Paulo-Brazil, Mayo Clinic-USA, San Francisco General Hospital-USA,  Cedars-Sinai Heart Institute-USA And Université Laval-Canada has found that the existing anti-inflammatory oral drug drug-Colchicine could be rep...
Source: COVID-19 Drugs  Jan 31, 2021  9 months ago
COVID-19 Drugs: Researchers from Emerging Pathogens Institute at Icahn School of Medicine at Mount Sinai and University of California-San Francisco’s Quantitative Bioscience Institute (QBI) have in a new study found a exsiting cancer drug called Aplidin effective against the SARS-CoV-2 coronavirus including the newly emergent B.1.1.7 variant.   The cancer drug Aplidin is mad...
Source: COVID-19 Antivirals  Jan 31, 2021  9 months ago
COVID-19 Antivirals: A new international research involving scientist from Universidad Católica de Valencia-Spain, Kyoto University-Japan, University of Vienna-Austria, Pingla Thana Mahavidyalaya-India, Indian Statistical Institute-India, University of South Florida-USA, University of Otago-New Zealand, University of Padova-Italy, Yarmouk University-Jordan, CSIR-Indian Institute of Chemical...
Source: COVID-19 Drugs  Jan 28, 2021  9 months ago
COVID-19 Drugs. While America and the United Kingdom along their so called ‘experts’ and corrupted politicians are constantly denouncing generic drugs that can be repurposed to treat COVID-19, supplements and herbs that can be used as adjuvants to also treat SARS-CoV-2 infections, more countries overseas are now beginning to accept ivermectin for use as both a prophylaxis and also as a...
Source: COVID-19 Drugs  Jan 24, 2021  9 months ago
COVID-19 Drugs: Researchers from the University of Bari Aldo Moro-Italy and the University Campus Bio-Medico of Rome have in a new study found that the diuretic drug Ethacrynic Acid could be repurposed to treat COVID-19.  The research findings are published in the peer reviewed journal: Viruses https://www.mdpi.com/1999-4915/13/1/106/htm   The SARS-CoV-2 coronavirus, the causative ...
Source: COVID-19 Drugs  Jan 14, 2021  9 months ago
COVID-19 Drugs: A new study by researchers from University of Birmingham-UK, Keele University-UK,  San Raffaele Scientific Institute-Italy, University of Copenhagen-Denmark and  the University of Liverpool-UK demonstrates that the  drug called Fenofibrate exhibits antiviral properties against the SARS-CoV- coronavirus and could be repurposed to treat COVID-19.   Fenofibrate, ...
Source: Ivermectin-COVID-19  Jan 12, 2021  9 months ago
Ivermectin-COVID-19: Indian researchers from the All India Institute of Medical Sciences have conducted a a double-blind, randomized, placebo-controlled clinical trial that demonstrated the efficacy of Ivermectin to treat COVID-19 disease. The clinical trial showed that Ivermectin, an anti-parasitic drug, can reduce in-hospital mortality rate COVID-19 patients. Ivermectin is currently being used ...
Source: Thailand Medical News  Jan 08, 2021  9 months ago
A new international study lead by medical researchers from Perelman School of Medicine at the University of Pennsylvania has found that common medications used to treat high blood pressure did not affect outcomes among patients hospitalized with COVID-19. This study findings provides relief to many as during the initial phases of the COVID-19 pandemic, there were speculations that certain blood pr...
Source: Pharma News  Jan 05, 2021  10 months ago
Pharma News: Florida based AzurRx BioPharma, a company specializing in the development of non-systemic therapies for gastrointestinal (GI) diseases has announced that it has signed an exclusive worldwide licensing agreement with First Wave Bio, Inc for the use of their patented and proprietary oral and rectal formulations of niclosamide for the treatment of immune checkpoint inhibitor-as...
Source: COVID-19 Drugs  Dec 18, 2020  10 months ago
COVID-19 Drugs: The second wave of the COVID-19 pandemic is currently taking a toll on numerous countries around the world with daily global infection rates now surpassing 700,000 and daily COVID-19 deaths now exceeding 13,000 (On December 16th new records were reported with more than 725,950 COVID-19 infections in 24 hours and 13,558 COVID-19 deaths).   As of Friday, (9am Bangkok time), th...
Source: Ivermectin and COVID-19  Dec 13, 2020  10 months ago
Ivermectin to treat COVID-19 in various stages of the disease is turning to be a more viable and proven option despite strong opposition from groups with vested interest in America and Europe.\ This time, a double blind, placebo- controlled randomized clinical trial tested the efficacy of the drug to treat mild conditions of the disease and to see how it prevents high viral loads, how it prevente...
Source: COVID-19 Antivirals  Dec 05, 2020  11 months ago
COVID-19 Antivirals: The interim WHO Solidarity Trial results confirms that antivirals like remdesivir, lopinavir, interferon and hydroxychloroquine seem to have little to no effect on mortality for hospitalized patients with COVID-19.   The trial randomly assigned hospitalized patients with Covid-19 equally between one of the trial drug regimens that was locally available and open control ...
Source: Supplements, Herbs and Repurposed Drugs For COVID-19  Dec 04, 2020  11 months ago
This simple guide to COVID-19 supplements, repurposed drugs and herbs that can help one with the COVID-19 is basically to help all around the world especially our readers in America, UK, the rest Of Europe, South America and India that has been badly affected by the COVID-19 pandemic and is going through a rough crisis in their countries.Please do due diligence first and never take any item below ...
Source: Molnupiravir   Dec 04, 2020  11 months ago
Molnupiravir:  As of the last count on Friday morning (4th December), sadly more than 276,120 Americans have died from the COVID-19 disease so far and more than 14.2 million COVID-19 infection cases were logged in the country. These figures are expected to rise exponentially in the next few months despite having so many ‘experts’ in the country.   It was reported that resea...
Source:   Nov 27, 2020  11 months ago
Ivermectin-COVID-19: Finally the results of a randomized trial has emerged to show the effectiveness of Ivermectin to treat COVID-19 despite numerous attempts by various big American and European pharmaceutical companies and their governments to try to suppress Ivermectin research due to greed and financial scams. The clinical trial study was led by Iranian researchers from Qazvin university of m...
Source: Coronavirus News  Nov 27, 2020  11 months ago
Coronavirus News: French researchers in a new multicenter study have found a lower or equal risk of fatal COVID-19 in hypertensive patients, depending on the type of medication they are on.   The study finding confirms earlier recommendations that antihypertensives should be continued in these patients before and during infection with SARS-CoV-2, the viral agent that causes COVID-19.  ...
COVID-19 Scams  Nov 24, 2020  11 months ago
American COVID-19 Scams: The Trump controlled U.S FDA, a regulatory agency that no longer has any credibility has suffered yet another blow as ethical medical professionals are advocating against the use of the overpriced drug bamlanivimab (Eli Lilly) that was granted emergency use authorization (EUA) by the U.S. FDA on the November 10th for use in ambulatory patients with mild to moderate COVID-1...

MOST READ

Feb 05, 2020  2 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  1 year ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  1 year ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  1 year ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  1 year ago
Source: Myocardial Injury
Jun 09, 2020  1 year ago
Source: COVID-19 News
May 21, 2020  1 year ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  2 years ago